4-nitro-N-(pyridin-2-ylmethyl)benzenesulfonamide | 111195-90-5

• 分子结构分类: 有机化合物 - 苯类化合物 - 苯和取代衍生物
• 英文名称: 4-nitro-N-(pyridin-2-ylmethyl)benzenesulfonamide
• 英文别名: 4-nitro-N-(2-pyridinylmethyl)benzenesulfonamide；4-nitro-N-(2-pyridylmethyl)benzenesulfonamide；4-Nitro-N-(2-pyridylmethyl)-1-benzenesulfonamide
• CAS: 111195-90-5
• 化学式: C₁₂H₁₁N₃O₄S
• mdl: MFCD00716720
• 分子量: 293.303
• InChiKey: NXIGSDAKUXYZOY-UHFFFAOYSA-N

物化性质

• 沸点：
  499.4±55.0 °C(Predicted)
• 密度：
  1.425±0.06 g/cm3(Predicted)

计算性质

• 辛醇/水分配系数(LogP)：
  1.2
• 重原子数：
  20
• 可旋转键数：
  4
• 环数：
  2.0
• sp3杂化的碳原子比例：
  0.08
• 拓扑面积：
  113
• 氢给体数：
  1
• 氢受体数：
  6

反应信息

• 作为反应物：
  描述：

  4-nitro-N-(pyridin-2-ylmethyl)benzenesulfonamide 在 potassium carbonate 、 苯硫酚 、 三苯基膦 、 偶氮二甲酸二乙酯 作用下， 以 N,N-二甲基甲酰胺 、 甲苯 、 苯 为溶剂， 反应 14.0h， 生成 (6-methyl-pyridin-2-ylmethyl)-pyridin-2-ylmethyl-amine
  参考文献：
  名称：

  Selective Zinc Sensor Molecules with Various Affinities for Zn²⁺, Revealing Dynamics and Regional Distribution of Synaptically Released Zn²⁺ in Hippocampal Slices

  摘要：

  We have developed a series of fluorescent Zn2+ sensor molecules with distinct affinities for Zn2+, because biological Zn2+ concentrations vary over a wide range from sub-nanomolar to millimolar. The new sensors have Kd values in the range of 10(-8)-10(-4) M, compared with 2.7 nM for ZnAF-2. They do not fluoresce in the presence of other biologically important metal ions such as calcium or magnesium, and they can detect Zn2+ within 100 ms. In cultured cells, the fluorescence intensity of ZnAF-2 was saturated at low Zn2+ concentration, while that of ZnAF-3 (K-d = 0.79 mu M) was not saturated even at relatively high Zn2+ concentrations. In hippocampal slices, we measured synaptic release of Zn2+ in response to high-potassium-induced depolarization. ZnAF-2 showed similar levels of fluorescence increase in dentate gyrus (DG), CA3 and CA1, which were indistinguishable. However, ZnAF-3 showed a fluorescence increase only in DG. Thus, by using a combination of sensor molecules, it was demonstrated for the first time that a higher Zn2+ concentration is released in DG than in CA3 or CA1 and that we can easily visualize Zn2+ concentration over a wide range. We believe that the use of various combinations of ZnAF family members will offer unprecedented versatility for fluorescence-microscopic imaging of Zn2+ in biological applications.

  DOI：

  10.1021/ja050301e
• 作为产物：
  描述：

  2-氨甲基吡啶 、 对硝基苯磺酰氯 生成 4-nitro-N-(pyridin-2-ylmethyl)benzenesulfonamide
  参考文献：
  名称：

  针对主要社区相关耐甲氧西林金黄色葡萄球菌菌株USA300的吸电子取代苯磺酰胺

  摘要：

  摘要合成了由磺酰胺组成的小型聚焦化学文库。这些化合物被设计为缺乏通常在磺酰胺抗生素中发现的对氨基苯部分。使用磁盘扩散和微量稀释试验研究了这些合成化合物对全球主要耐甲氧西林金黄色葡萄球菌（MRSA）菌株USA300（SF8300）和金黄色葡萄球菌（S. aureus）对照菌株ATCC 25923和ATCC 29213的抗菌活性。根据药敏结果，可检测到强力的金黄色葡萄球菌和MRSA USA300生长抑制剂，例如N发现具有最低抑制浓度（MIC）低至5.6μg/ cm 3的-[3,5-双（三氟甲基）苯基] -4-溴苯磺酰胺以及其他有效的磺酰胺。结构与活性的关系表明，这些脱氨基苯磺酰胺需要吸电子取代基才能有效抑制细菌病原体的生长。另外，即使当细菌叶酸合成中间体p时，它们仍具有抑制金黄色葡萄球菌菌株生长的能力。-氨基苯甲酸（PABA）被补充，而PABA补充则完全削弱了已知的磺胺药，磺胺甲恶唑的抗菌活性

  DOI：

  10.1007/s00706-013-0937-3

文献信息

• Activity-based ratiometric FRET probe reveals oncogene-driven changes in labile copper pools induced by altered glutathione metabolism
  作者：Clive Yik-Sham Chung、Jessica M. Posimo、Sumin Lee、Tiffany Tsang、Julianne M. Davis、Donita C. Brady、Christopher J. Chang

  DOI：10.1073/pnas.1904610116

  日期：2019.9.10

  growing biology, we report a first-generation ratiometric fluorescence resonance energy transfer (FRET) copper probe, FCP-1, for activity-based sensing of labile Cu(I) pools in live cells. FCP-1 links fluorescein and rhodamine dyes through a Tris[(2-pyridyl)methyl]amine bridge. Bioinspired Cu(I)-induced oxidative cleavage decreases FRET between fluorescein donor and rhodamine acceptor. FCP-1 responds

  铜是生命必不可少的元素，除了其作为酶功能的紧密结合的，具有氧化还原活性的活性位点辅助因子的公认功能之外，新兴数据表明，细胞铜也存在于不稳定的池中，定义为与低分子松散结合重量的配体，可以调节多种过渡金属信号传导过程，包括神经通讯和嗅觉，脂解作用，静息活动周期以及对致癌信号至关重要的激酶途径。为了帮助解释这种不断发展的生物学，我们报告了第一代比率式荧光共振能量转移（FRET）铜探针FCP-1，用于基于活性的活细胞中不稳定Cu（I）池的传感。FCP-1通过三[（2-吡啶基）甲基]胺桥连接荧光素和若丹明染料。生物启发的铜（I）诱导的氧化裂解降低了荧光素供体和若丹明受体之间的FRET。FCP-1以高的金属选择性和氧化态特异性响应Cu（I），并有助于进行比例式测量，以最大程度地减少由于样品厚度，染料浓度和光强度变化而引起的潜在干扰。FCP-1能够对活细胞中不稳定的Cu（I）库中的动态变化进行成像，以响
• [EN] PROBES FOR DETECTION OF COPPER<br/>[FR] SONDES POUR LA DÉTECTION DE CUIVRE
  申请人：UNIV CALIFORNIA

  公开号：WO2020226972A1

  公开（公告）日：2020-11-12

  The present disclosure provides Förster resonance energy transfer (FRET)-based probes for detecting copper, e.g., for detecting Cu(I) in live cells. The present disclosure provides methods for detecting copper, e.g., for detecting Cu(I) in live cells, using a FRET-based probe of the present disclosure.

  本公开提供了一种基于Förster共振能量转移（FRET）的探针，用于检测铜，例如，用于检测活细胞中的Cu(I)。本公开提供了使用本公开的FRET探针检测铜的方法，例如用于检测活细胞中的Cu(I)。
• BET-PROTEIN-INHIBITING DIHYDROPYRIDOPYRAZINONES
  申请人：BAYER PHARMA AKTIENGESELLSCHAFT

  公开号：US20160193206A1

  公开（公告）日：2016-07-07

  The present invention relates to BET protein-inhibitory, especially BRD4-inhibitory, dihydropyridopyrazinones of the general formula (I) in which A, X, R 1 , R 2 , R 3 , R 4 , R 4 , R 6 , R 7 and n have the meanings given in the description, to intermediates for preparation of the compounds according to the invention, to pharmaceutical compositions comprising the compounds according to the invention, and to the prophylactic and therapeutic use thereof in the case of hyperproliferative disorders, especially in the case of neoplastic disorders. This invention further relates to the use of BET protein inhibitors in viral infections, in neurodegenerative disorders, in inflammation diseases, in atherosclerotic disorders and in male fertility control.

  本发明涉及BET蛋白抑制剂，特别是BRD4抑制剂，通式（I）所示的二氢吡啶吡唑酮，其中A、X、R1、R2、R3、R4、R4、R6、R7和n在说明书中给出其含义，以及制备本发明化合物的中间体，包含本发明化合物的制药组合物，以及在高增殖性疾病，特别是恶性肿瘤疾病的预防和治疗中的预防和治疗用途。本发明还涉及在病毒感染、神经退行性疾病、炎症性疾病、动脉粥样硬化性疾病和男性生育控制中使用BET蛋白抑制剂。
• Acyl derivatives of p-aminosulfonamides and dapsone as new inhibitors of the arginine methyltransferase hPRMT1
  作者：Elisabeth-Maria Bissinger、Ralf Heinke、Astrid Spannhoff、Adrien Eberlin、Eric Metzger、Vincent Cura、Pierre Hassenboehler、Jean Cavarelli、Roland Schüle、Mark T. Bedford、Wolfgang Sippl、Manfred Jung

  DOI：10.1016/j.bmc.2011.02.032

  日期：2011.6

  Arginine methylation is an epigenetic modification that receives increasing interest as it plays an important role in several diseases. This is especially true for hormone-dependent cancer, seeing that histone methylation by arginine methyltransferase I (PRMT1) is involved in the activation of sexual hormone receptors. Therefore, PRMT inhibitors are potential drugs and interesting tools for cell biology. A dapsone derivative called allantodapsone previously identified by our group served as a lead structure for inhibitor synthesis. Acylated derivatives of p-aminobenzenesulfonamides and the antilepra drug dapsone were identified as new inhibitors of PRMT1 by in vitro testing. The bis-chloroacetyl amide of dapsone selectively inhibited human PRMT1 in the low micromolar region and was selective for PRMT1 as compared to the arginine methyltransferase CARM1 and the lysine methyltransferase Set7/9. It showed anticancer activity on MCF7a and LNCaP cells and blocked androgen dependent transcription specifically in a reporter gene system. Likewise, a transcriptional block was also demonstrated in LNCaP cells using quantitative RT-PCR on the mRNA of androgen dependent genes. (C) 2011 Elsevier Ltd. All rights reserved.
• Novel 1,4-naphthoquinone-based sulfonamides: Synthesis, QSAR, anticancer and antimalarial studies
  作者：Ratchanok Pingaew、Veda Prachayasittikul、Apilak Worachartcheewan、Chanin Nantasenamat、Supaluk Prachayasittikul、Somsak Ruchirawat、Virapong Prachayasittikul

  DOI：10.1016/j.ejmech.2015.09.001

  日期：2015.10

  A novel series of 1,4-naphthoquinones (33-44) tethered by open and closed chain sulfonamide moieties were designed, synthesized and evaluated for their cytotoxic and antimalarial activities. All quinone-sulfonamide derivatives displayed a broad spectrum of cytotoxic activities against all of the tested cancer cell lines including HuCCA-1, HepG2, A549 and MOLT-3. Most quinones (33-36 and 38-43) exerted higher anticancer activity against HepG2 cell than that of the etoposide. The open chain analogs 36 and 42 were shown to be the most potent compounds. Notably, the restricted sulfonamide analog 38 with 6,7-dimethoxy groups exhibited the most potent antimalarial activity (IC50 = 2.8 mu M). Quantitative structure activity relationships (QSAR) study was performed to reveal important chemical features governing the biological activities. Five constructed QSAR models provided acceptable predictive performance (R-cv, 0.5647-0.9317 and RMSEcv 0.1231-0.2825). Four additional sets of structurally modified compounds were generated in silico (34a-34d, 36a-36k, 40a-40d and 42a-42k) in which their activities were predicted using the constructed QSAR models. A comprehensive discussion of the structure activity relationships was made and a set of promising compounds (i.e., 33, 36, 38, 42, 36d, 36f, 42e, 42g and 42f) was suggested for further development as anticancer and antimalarial agents. (C) 2015 Elsevier Masson SAS. All rights reserved.